KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Times Interest Earned (2017 - 2025)

Regeneron Pharmaceuticals (REGN) has 16 years of Times Interest Earned data on record, last reported at $72.12 in Q4 2025.

  • For Q4 2025, Times Interest Earned fell 23.52% year-over-year to $72.12; the TTM value through Dec 2025 reached $81.69, up 12.99%, while the annual FY2025 figure was $81.69, 12.99% up from the prior year.
  • Times Interest Earned reached $72.12 in Q4 2025 per REGN's latest filing, up from $53.2 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $299.86 in Q2 2025 and bottomed at $46.67 in Q1 2024.
  • Average Times Interest Earned over 5 years is $86.08, with a median of $72.12 recorded in 2025.
  • Peak YoY movement for Times Interest Earned: tumbled 43.16% in 2023, then skyrocketed 314.92% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at $130.08 in 2021, then plummeted by 49.33% to $65.91 in 2022, then fell by 19.34% to $53.16 in 2023, then surged by 77.38% to $94.3 in 2024, then fell by 23.52% to $72.12 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were $72.12 in Q4 2025, $53.2 in Q3 2025, and $299.86 in Q2 2025.